The use of burosumab to treat autosomal-recessive hypophosphatemic rickets type 2: rationale and a first clinical experience

J Nephrol. 2024 Feb 3. doi: 10.1007/s40620-023-01884-6. Online ahead of print.NO ABSTRACTPMID:38308754 | DOI:10.1007/s40620-023-01884-6

Source: Journal of Nephrology - February 3, 2024 Category: Urology & Nephrology Authors: Mattia Parolin Nicola Bertazza Partigiani Elisa Benetti Germana Longo Enrico Vidal Source Type: research